Advertisement
Screener

SIERRA ONCOLOGY, INC. Patents: Active

SIERRA ONCOLOGY, INC. Active Patents

6 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2021-02-05: Application 17266262; Invention Platelet Count-Agnostic Methods of Treating Myelofibrosis; Applicant Sierra Oncology, Inc.; Status Patented Case.
  • 2020-09-04: Application 17013342; Invention N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-YL) Benzamide; Applicant SIERRA ONCOLOGY, INC.; Status Patented Case.
  • 2019-10-09: Application 16604116; Invention CHK1 (SRA737)/; Applicant SIERRA ONCOLOGY, INC.; Status Patented Case.
  • 2018-10-18: Application 16164681; Invention N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-YL) Benzamide; Applicant SIERRA ONCOLOGY, INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2021-02-0517266262Platelet Count-Agnostic Methods of Treating MyelofibrosisSierra Oncology, Inc.Patented Case2024-04-2311963962US20210299132A1
Barbara Jane Klencke
Gregg David Smith
Rafe Michael Joseph Donahue
United States
United States
United States
SHAMEEM, GOLAM M
2020-09-0417013342N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-YL) BenzamideSIERRA ONCOLOGY, INC.Patented Case2023-03-07RE49445
Brandon H. Brown
Ernest A. Carra
Jeffrey N. Hemenway
Henry Morrison
Troy Reynolds
Bing Shi
Dimitrios Stefanidis
Fang Wang
Matthew Robert Warr
James Andrew Whitney
Yan Xin
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
JOHNSON, JERRY D
2019-10-0916604116CHK1 (SRA737)/PARPI COMBINATION METHODS OF INHIBITING TUMOR GROWTHSIERRA ONCOLOGY, INC.Patented Case2023-03-0711596637US20210077499A1
Christian Andrew HASSIG
Bryan William STROUSE
Ryan James HANSEN
Kenna Lynn ANDERES
United States
United States
United States
United States
ANDERSON, JAMES D
2018-10-1816164681N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-YL) BenzamideSIERRA ONCOLOGY, INC.Patented Case2020-10-27RE48285
Brandon H. BROWN
Ernest A. CARRA
Jeffrey N. HEMENWAY
Henry MORRISON
Troy REYNOLDS
Bing SHI
Dimitrios STEFANIDIS
Fang WANG
Matthew Robert WARR
James Andrew WHITNEY
Yan XIN
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
DIAMOND, ALAN D
2017-08-0815671978TREATMENT OF ACVR1-MEDIATED DISEASESSierra Oncology Inc.Patented Case2019-04-0210245268US20180042933A1
Brian Koh
Igor Theurl
Matthew Robert Warr
James Andrew Whitney
United States
Austria
United States
United States
RAO, SAVITHA M
2010-03-1912530610PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOFSIERRA ONCOLOGY, INC.Patented Case2013-07-168486941US20100197671A1
Christopher John Burns
Andrew Craig Donohue
John Thomas Feutrill
Thao Lien Thi Nguyen
Andrew Frederick Wilks
Jun Zeng
Australia
Australia
Australia
Australia
Australia
Australia
WANG, SHENGJUN